Reliance Life Sciences Private Limited
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.
Dosage form: lyophilisate for solution for injection
Active substance Dosage bortezomib 1 mg ATC: L01XX32
-
The drug is used for the treatment of multiple myeloma (as monotherapy or as part of combination therapy) and mantle cell lymphoma.
Dosage form: lyophilisate for solution for injection
Active substance Dosage bortezomib 3.5 mg ATC: L01XX32
-
The drug is used for the treatment of malignant unresectable pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).
Dosage form: powder for solution for infusion
Active substance Dosage pemetrexed 100 mg ATC: L01BA04
-
The drug is used for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as a single agent for maintenance or second-line therapy).
Dosage form: powder for solution for infusion
Active substance Dosage pemetrexed 500 mg ATC: L01BA04